Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 55 | 58 | 57 | 57 | 56 |
| Accounts receivable | -96 | 63 | -106 | 917 | -165 |
| Other Working Capital | -1,035 | 6,645 | 705 | 1,308 | -343 |
| Other Operating Activity | -6,008 | -9,355 | -3,639 | -3,467 | -1,978 |
| Operating Cash Flow | $-7,084 | $-2,589 | $-2,983 | $-1,185 | $-2,429 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -13 | -7 | -2 | -18 |
| Investing Cash Flow | $0 | $-13 | $-7 | $-2 | $-18 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13 | -13 | -13 | -12 | -12 |
| Common Stock Issued | N/A | 0 | 0 | 17,250 | 0 |
| Other Financing Activity | 11,076 | 94 | 115 | -1,114 | 0 |
| Financing Cash Flow | $11,063 | $81 | $102 | $16,124 | $-12 |
| Beginning Cash Position | 14,025 | 16,547 | 19,434 | 4,497 | 6,956 |
| End Cash Position | 18,004 | 14,025 | 16,547 | 19,434 | 4,497 |
| Net Cash Flow | $3,979 | $-2,521 | $-2,887 | $14,937 | $-2,459 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,084 | -2,589 | -2,983 | -1,185 | -2,429 |
| Capital Expenditure | N/A | -13 | -7 | -2 | -18 |
| Free Cash Flow | -7,084 | -2,602 | -2,990 | -1,187 | -2,447 |